ERS Genomics and IRBM sign deal for CRISPR technology

ERS Genomics and IRBM have signed a deal granting the latter access to ERS Genomics' extensive CRISPR/Cas9 patent portfolio.

Related Keywords

Carlo Toniatti ,John Milad ,Emmanuelle Charpentier , ,